Skip to main content

Join the Medicinal Cannabis Primary Dysmenorrhoea (Period Pain) Study

Expert medical support will be provided free of charge.
The cost of medicinal cannabis throughout the study will be offered to you at a 20% discounted price.
Limited places – apply now.

Researchers from NICM, Western Sydney University are conducting a study on the effectiveness of medicinal cannabis products for managing period pain (Primary Dysmenorrhoea), as well as related symptoms such as cramping, mood changes, and sleep disturbance.

If you are a woman aged between 18 and 45 years and regularly experience moderate to severe period pain, you may be eligible to participate.

You will have a telehealth appointment with Natura Healthcare Clinic, and if suitable, a doctor will prescribe the appropriate medicinal cannabis products. The study will involve about 10 minutes of your time each month over six months.

Join the Medicinal Cannabis for Primary Dysmenorrhoea (Period Pain) Study

Researchers from NICM, Western Sydney University are conducting a study on the effectiveness of medicinal cannabis products for managing period pain (Primary Dysmenorrhoea), as well as related symptoms such as cramping, mood changes, and sleep disturbance.

If you are a woman aged between 18 and 45 years and regularly experience moderate to severe period pain, you may be eligible to participate.

You will have a telehealth appointment with Natura Healthcare Clinic, and if medicinal cannabis is deemed suitable, a doctor will prescribe the appropriate medicinal cannabis products. The study will involve about 10 minutes of your time each month over six months.

Consultations will be provided free of charge.
The cost of medicinal cannabis throughout the study will be offered to you at a 20% discounted price.
Limited places – apply now.

What’s involved?

This study has been designed for real-world participation. Everything occurs online or in your local community, with study medications delivered right to your door.

Pre-screening survey (15 minutes to complete).
Pathology appointment (blood test) in your local area.
Telehealth appointment with our caring doctor, and if suitable, a prescription will be issued for medicinal cannabis.
Study medications are delivered to your door securely and discreetly by post.
A monthly survey and check in, for six months, with as much support from our research and clinical team as you require.

Who can participate?

• Women living anywhere in Australia.
• Aged 20 years or over
• Have primary dysmenorrhoea.
• Not have used medical cannabis within the last three months.
• Be willing to use contraception for the duration of the study.
• Be able to complete online study questionnaires.
Call 1300 413 379
Not sure? The team can help

What’s involved?

This study has been designed for real-world participation. Everything occurs online or in your local community, with study medications delivered right to your door.

Pre-screening survey
(15 minutes to complete).
Pathology appointment (blood test) in your local area.
Telehealth appointment with our caring doctor, and if suitable, a prescription will be issued for medicinal cannabis.
Study medications are delivered to your door securely and discreetly by post.
A monthly survey and check in, for six months, with as much support from our research and clinical team as you require.

Who can participate?

• Women living anywhere in Australia.
• Aged 20 years or over
• Have primary dysmenorrhoea.
• Not have used medical cannabis within the last three months.
• Be willing to use contraception for the duration of the study.
• Be able to complete online study questionnaires.
Not sure? The team can help
Call 1300 413 379

FAQs

Can I still drive while participating in the study?

No. Currently it is illegal to drive with any Delta-9-tetrahydrocannabinol (THC) in your system, even if not impaired. THC, which can cause psychoactive effects when consumed is present in all products in the study formulary (including our full spectrum CBD oil). While the amount may be very low, and you may not feel any effects, THC can remain present in the body for many days or weeks. This applies to all States and Territories.

I’ve previously used cannabis products for my Primary Dysmenorrhoea symptoms but did not find it helpful. How can this study help me?

In this study, doctors at Natura Clinic will individualise cannabis medications and their dosing for you based on your symptoms, your circumstances, and your preferences. The study formulary includes oils, flower, and vapes for inhalation, with a variety of strengths and formulations. The study doctors are very experienced in providing clinical care and will work with you to manage your symptoms in a way that suits you, and will guide you throughout the process. You can discuss treatment options during the telehealth consultations which are a part of the study, and you can speak to the friendly study team on weekdays at any time. If you have any doubts, call the study team on 1300 413 379 and they will talk you through your eligibility and answer any questions you may have.

I have recently consumed cannabis - can I still participate?

Yes! Even if you currently use or have used cannabis in the past two months, you may still be eligible to participate following an eight week wash out period. That means, you need to be cannabis free for 8 weeks before beginning the study. Call now, and we can place you on the study waitlist so that in eight weeks you can begin without delay. There are a number of women currently completing washout periods to participate in the study.

I have never tried cannabis - can I still participate?

Absolutely! As long as you meet the other eligibility criteria, you are most welcome. Many people try medicinal cannabis for the first time as a part of research. Under the care of our experienced doctors and study team you will have full support to explore cannabis as a therapeutic option to manage your symptoms. Call the study team on 1300 413 379 and they will talk you through your eligibility and answer any questions you may have.

To contact the Study Coordinator:

Toobah Farooqi, Clinical Trial Officer – Women’s Health NICM Health Research Institute, Western Sydney University
Human Research Ethics Committee Approval: This clinical trial has been approved by the Western Sydney University Human Research Ethics Committee (Approval Number: H15819).
This study is funded by Cannim Group Pty Ltd.